[1]Dekker E, Tanis JP, Vleugels J, et al. Colorectal cancer[J]. Lancet, 2019, 394: 1467-1480. [2]张梦迪,王亚南,李杰,等. 雷帕霉素下调mTOR-GP73通路抑制结直肠癌进程[J]. 基础医学与临床, 2020, 40: 934-939. [3]Dong Z, Zou J, Li J, et al. MYST1/KAT8 contributes to tumor progression by activating EGFR signaling in glioblastoma cells[J]. Cancer Med, 2019, 8: 7793-7808. [4]Qiu B, Li S, Li M, et al. KAT8 acetylation-controlled lipolysis affects the invasive and migratory potential of colorectal cancer cells[J]. Cell Death Dis, 2023, 14: 164. doi: 10.1038/s41419-023-05582-w. [5]Yang Y, Han X, Guan J, et al. Regulation and function of histone acetyltransferase MOF[J]. Front Med, 2014, 8: 79-83. [6]Deng JL, Deng QW, Fan RS, et al. M6A modification: recent advances, anticancer targeted drug discovery and beyond[J]. Mol Cancer, 2022, 21: 52. doi: 10.1186/s12943-022-01510-2. [7]Sendinc E, Shi Y. RNA m6A methylation across the transcriptome[J]. Mol Cell, 2023, 83: 428-441. [8]廖镇城,杨思懿,吴平安. 提高m6A去甲基化酶FTO表达抑制鼻咽癌细胞增殖[J]. 基础医学与临床, 2024, 44: 57-62. [9]Fang Z, Mei W, Qu C, et al. Role of m6A writers, erasers and readers in cancer[J]. Exp Hematol Oncol, 2022, 11: 45. doi: 10.1186/s40164-022-00298-7. [10]Zhu W, Si Y, Xu J, et al. Methyltransferase like 3 promotes colorectal cancer proliferation by stabilizing CCNE1 mRNA in an m6A-dependent manner[J]. J Cell Mol Med, 2020, 24: 3521-3533. [11]Li T, Hu S P, Zuo Z, et al. METTL3 facilitates tumor progression via an m(6)A-IGF2BP2-dependent mechan-ism in colorectal carcinoma[J]. Mol Cancer, 2019, 18: 112. doi: 10.1186/s12943-019-1038-7. |